The YTHDC1-m⁶A-GADD45B axis promotes chondrogenesis of hPDLSCs via suppressing senescence through p53/p21 signalling pathway

Abstract

Temporomandibular joint osteoarthritis (TMJOA) is a degenerative disease with limited therapeutic options. Stem cell-based tissue engineering, particularly utilizing human periodontal ligament stem cells (hPDLSCs), represents a promising approach for cartilage regeneration. However, we have previously demonstrated that chronic inflammation and hypoxic stress in the TMJOA microenvironment markedly accelerate cellular senescence in hPDLSCs, severely impairing their regenerative potential. Here, we identify the YTHDC1–m⁶A–GADD45B axis as a critical regulator of senescence and chondrogenic differentiation in hPDLSCs. We show that YTHDC1, an m⁶A reader protein, is downregulated under inflammatory and senescent conditions. Functional studies reveal that YTHDC1 overexpression attenuates senescence and enhances chondrogenesis, whereas its knockdown exacerbates senescence and suppresses differentiation. Mechanistically, YTHDC1 recognizes m⁶A modifications on GADD45B mRNA and promotes its decay, leading to inhibition of the p53/p21 signaling pathway. Mutation of the m⁶A site in GADD45B abolishes the regulatory effects of YTHDC1. In rats with TMJOA, transplantation of YTHDC1–overexpressing hPDLSCs ameliorated disease phenotypes, an effect reversed by co-expression of wild-type GADD45B. Our findings reveal a novel epitranscriptomic mechanism that regulates hPDLSCs senescence and subsequently affects chondrogenic differentiation, and highlight the therapeutic potential of targeting the YTHDC1-GADD45B-p53/p21 axis.

References

[1] Xing L, Qi X, Liu Y, Wu J, Jiang B. Ectodysplasin-A deficiency exacerbates TMJOA by upregulating ATF4/Ihh signaling in mice. Osteoarthr. Cartil., 2025, 33: 965-979.

[2] Lei J, et al.. Inhibiting Hh signaling in Gli1(+) osteogenic progenitors alleviates TMJOA. J. Dent. Res., 2022, 101: 664-674.

[3] Liu X, et al.. TREM2 activation relieves TMJOA by stabilizing the synovial barrier via siglec1. J. Dent. Res., 2025, 104: 1003-1013.

[4] Zhang J, et al.. PTHrP promotes subchondral bone formation in TMJ-OA. Int. J. Oral. Sci., 2022, 14: 37.

[5] Pan X, Zhao Z, Huang X, Cen X. Circ-Slain2 alleviates cartilage degradation and inflammation of TMJOA. J. Dent. Res., 2023, 102: 1498-1506.

[6] Huang K, et al.. Cartilage-penetrating framework nucleic acid nanoparticles ameliorate osteoarthritis by promoting drug delivery and chondrocyte uptake. Adv. Sci., 2025, 12: e2502661.

[7] Wang L, et al.. Adult stem cells and hydrogels for cartilage regeneration. Curr. Stem Cell Res. Ther., 2018, 13: 533-546.

[8] Zheng C, Chen J, Liu S, Jin Y. Stem cell-based bone and dental regeneration: a view of microenvironmental modulation. Int. J. Oral. Sci., 2019, 11: 23.

[9] Liu W, et al.. Melatonin abates TMJOA chronic pain by MT(2)R in trigeminal ganglion neurons. J. Dent. Res., 2022, 101: 111-119.

[10] Liu X, et al.. ALPK1 aggravates TMJOA cartilage degradation via NF-kappaB and ERK1/2 signaling. J. Dent. Res., 2022, 101: 1499-1509.

[11] Wang M, et al.. Betaine enhances SCAPs chondrogenic differentiation and promotes cartilage repair in TMJOA through WDR81. Stem Cell Res. Ther., 2025, 16: 55.

[12] Huang K, et al.. Cartilage tissue regeneration: the roles of cells, stimulating factors and Scaffolds. Curr. Stem Cell Res. Ther., 2018, 13: 547-567.

[13] Calabrese EJ. Human periodontal ligament stem cells and hormesis: Enhancing cell renewal and cell differentiation. Pharm. Res., 2021, 173: 105914.

[14] Bi R, et al.. Divergent chondro/osteogenic transduction laws of fibrocartilage stem cell drive temporomandibular joint osteoarthritis in growing mice. Int. J. Oral. Sci., 2023, 15: 36.

[15] Yuan W, et al.. Strontium-Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment. Int. J. Oral. Sci., 2025, 17: 6.

[16] Ma Z, et al.. Effect of regional crosstalk between sympathetic nerves and sensory nerves on temporomandibular joint osteoarthritic pain. Int. J. Oral. Sci., 2025, 17: 3.

[17] Liu J, et al.. The RNA m(6)A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature, 2021, 591: 322-326.

[18] Wu T, et al.. METTL3-m(6) A methylase regulates the osteogenic potential of bone marrow mesenchymal stem cells in osteoporotic rats via the Wnt signalling pathway. Cell Prolif., 2022, 55: e13234.

[19] Dai C, Tang Y, Yang H, Zheng J. YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. Mol. Cell, 2025, 85: 2733-2748.e2737.

[20] Jiang Z, et al.. M(6)A demethyltransferase FTO attenuates meniscus degeneration and osteoarthritis via orchestrating autophagy and energetic metabolism. Adv. Sci., 2025, 12: e2412379.

[21] Ye G, et al.. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression. Exp. Mol. Med., 2023, 55: 1743-1756.

[22] Zuo HN, et al.. YTHDC1-mediated microRNA maturation is essential for hematopoietic stem cells maintenance. Cell Death Discov., 2024, 10: 439.

[23] Qiao Y, et al.. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export. Elife, 2023, 12: e82703.

[24] Ge X, et al.. The loss of YTHDC1 in gut macrophages exacerbates inflammatory bowel disease. Adv. Sci., 2023, 10: e2205620.

[25] Zhang C, et al.. YTHDC1 delays cellular senescence and pulmonary fibrosis by activating ATR in an m6A-independent manner. EMBO J., 2024, 43: 61-86.

[26] Palomer X, et al.. GADD45A: with or without you. Med. Res. Rev., 2024, 44: 1375-1403.

[27] Wu C, et al.. Contradictory role of Gadd45beta in liver diseases. J. Cell Mol. Med., 2024, 28: e70267.

[28] Zhang X, et al.. Global transcriptome analysis to identify critical genes involved in the pathology of osteoarthritis. Bone Jt. Res., 2018, 7: 298-307.

[29] Wang J, et al.. beta-catenin orchestrates Gli1+ cell fate in condylar development and TMJOA. J. Dent. Res., 2024, 103: 1291-1301.

[30] An N, et al.. Human periodontal ligament stem cell sheets activated by graphene oxide quantum dots repair periodontal bone defects by promoting mitochondrial dynamics dependent osteogenic differentiation. J. Nanobiotechnol., 2024, 22. ArticleID: 133

[31] Sun Y, et al.. Injectable periodontal ligament stem cell-metformin-calcium phosphate scaffold for bone regeneration and vascularization in rats. Dent. Mater., 2023, 39: 872-885.

[32] Chen BY, et al.. Inflammation triggers chondrocyte ferroptosis in TMJOA via HIF-1alpha/TFRC. J. Dent. Res., 2024, 103: 712-722.

[33] Ao K, et al.. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer. Cancer Lett., 2024, 587: 216658.

[34] Chelmicki T, et al.. m(6)A RNA methylation regulates the fate of endogenous retroviruses. Nature, 2021, 591: 312-316.

[35] Chen L, Liu J, Rao Z. FTO-overexpressing extracellular vesicles from BM-MSCs reverse cellular senescence and aging to ameliorate osteoarthritis by modulating METTL3/YTHDF2-mediated RNA m6A modifications. Int. J. Biol. Macromol., 2024, 278: 134600.

[36] Chen L, et al.. Has-miR-300-GADD45B promotes melanoma growth via cell cycle. Aging, 2023, 15: 13920-13943.

[37] Guo C, et al.. EPO deficiency upregulates GADD45b/p38 MAPK Axis, mediating schizophrenia-related synaptic and cognitive impairments. Adv. Sci., 2024, 11: e2406979.

[38] Xie M, Xie R, Huang P, Yap DYH, Wu P. GADD45A and GADD45B as novel biomarkers associated with chromatin regulators in renal ischemia-reperfusion injury. Int. J. Mol. Sci., 2023, 24: 11304.

[39] Zhan Y, et al.. DNA hypomethylation-mediated upregulation of GADD45B facilitates airway inflammation and epithelial cell senescence in COPD. J. Adv. Res., 2025, 68: 201-214.

[40] Li Y, Meng L, Zhao B. The roles of N6-methyladenosine methylation in the regulation of bone development, bone remodeling and osteoporosis. Pharm. Ther., 2022, 238: 108174.

[41] Gao L, Lee H, Goodman JH, Ding L. Hematopoietic stem cell niche generation and maintenance are distinguishable by an epitranscriptomic program. Cell, 2024, 187: 2801-2816.e2817.

[42] Wen J, et al.. Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal. Mol. Cell, 2018, 69: 1028-1038 e1026.

[43] Wu Y, et al.. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat. Commun., 2018, 9. ArticleID: 4772

[44] Yankova E, et al.. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature, 2021, 593: 597-601.

[45] Lv D, et al.. Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2. Cell Metab., 2024, 36: 2419-2436 e2418.

[46] Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone, 2012, 51: 204-211.

[47] Kwan Tat S, et al.. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum., 2008, 58: 3820-3830.

[48] Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol., 2012, 8: 665-673.

Funding

Science & Technology Department of Sichuan Province (2024NSFSC2087), Open Project of State Key Laboratory of Oral Diseases (SKLOD2025OF05), Science and Technology Project of Health Commission of Sichuan Province (24WXXT11),Scientific and Technological Project of Luzhou (2025MYF002, 2025MYF024)

Scientific and Technological Project of Luzhou (2022-JYJ-107), 2023 Key Project of The Affiliated Stomatological Hospital of Southwest Medical University (2023Z02) and Stomatological Special Fund of Southwest Medical University (2024KQZX08)

RIGHTS & PERMISSIONS

The Author(s)